The nicotinic modulation of pain | [Pakistan Journal of Pharmaceutical Sciences • 2020]

Author(s):

1. Nurcan Bektas: Anadolu University Faculty of Pharmacy, Department of Pharmacology,Eskisehir,Turkey

2. Dilara Nemutlu: Anadolu University Faculty of Pharmacy, Department of Pharmacology,Eskisehir,Turkey

3. Mevcude Cam: Anadolu University Faculty of Pharmacy, Department of Pharmacology,Eskisehir,Turkey

4. Yagmur Okcay: Anadolu University Faculty of Pharmacy, Department of Pharmacology,Eskisehir,Turkey

5. Hazal Eken: Anadolu University Faculty of Pharmacy, Department of Pharmacology,Eskisehir,Turkey

6. Rana Arslan: Anadolu University Faculty of Pharmacy, Department of Pharmacology,Eskisehir,Turkey

Abstract:

Pain is a physiological unpleasant sensation that associated with actual or potential tissue damage and affects the major part of human population. Numerous modulatory system control pain through a complex process. The drugs that regulate the modulators involving in this process are currently available; however, the studies to understand the process and develop new agents are still going on. In this review, it is aimed to relay information about how nicotinic receptors contribute the pain modulation. It is obvious that a wide variety of nicotinic receptors is located in both peripheral and central areas. Among these receptors a7, a4ß2 and a9a10 receptor subtypes draw attention in terms of pain modulation. The fact that different receptor subtypes involve in different processes of different pain conditions leads to provide beneficial results from the agonism of a7, a4ß2 and antagonism of a9a10. The major restraint of the usage of nAChR agonists is their adverse effects. However, nowadays, the side effects are reduced by the clinical developments. Additionally, positive allosteric modulators that amplify the effectiveness of nAChR ligands are in demand.

Page(s): 229-239

DOI: DOI not available

Published: Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: 1, Year: 2020

Keywords:

positive allosteric modulators , nicotinic receptors

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views